API Product   :    Mirtazapine
CEP   :    ¤
WCC   :    ?
Therapeutic Use    :    Psychoanaleptics Excluding Anti-Obesity Preparations
Psychoanaleptics Excluding Anti-Obesity Preparations
Originator   :    Organon
CAS No.    :    61337-67-5
Trade Name.   :    REMERON
Molecular Weight   :    265.35 g/mol
Molecular Formula   :    C17H19N3
Mirtazapine is the generic form of the brand-name antidepressant Remeron, which is used to treat depression and other ailments. In some patients, depression may be associated with abnormal levels of neurotransmitters, the brain chemicals that nerve cells use to communicate with each other.
Mirtazapine, sold under the brand name Remeron among others, is an antidepressant primarily used to treat depression. Its full effect may take more than four weeks to occur, with some benefit possibly as early as one to two weeks. Often it is used in depression complicated by anxiety or trouble sleeping. It is taken by mouth. Common side effects include increased weight, sleepiness, and dizziness. Serious side effects may include an increased suicide among children, mania, and low white blood count. Withdrawal symptoms may occur with stopping. It is not recommended together with an MAO inhibitor. It is unclear if use during pregnancy is safe. How it works is not clear but may involve blocking certain adrenergic and serotonin receptors. Chemically, it is a tetracyclic antidepressant (TeCA). It also has strong antihistamine effects.